ENESDENewsletter →
Shotlee
Get the app
📖Complete Guide✅Updated 2026🔬Evidence-Based

FOXO4-DRI Guide (2026)

Complete Guide & Evidence (2026)

Senolytic peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction. Anti-aging research compound.

Download on theApp Store
Get it onGoogle Play
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
⌄
ACTIVE MEDICATIONS
Foxo4 DriB12
FOXO4 DRI
🔥 14
2
days away
Thursday · 7.5mg
⌄
Medication Supply
Foxo4 Dri
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
Foxo4 DriRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
Dashboard
Your complete health overview in one place
🔥
14-day streak
Logged 18 of 18 scheduled shots
Next Shot Reminder
⌄
ACTIVE MEDICATIONS
Foxo4 DriB12
FOXO4 DRI
🔥 14
2
days away
Thursday · 7.5mg
⌄
Medication Supply
Foxo4 Dri
6.2 / 10 mg · Vial
~42 days left · Mar 15
B12
4.4 / 5 ml · Vial
~88 days left · May 8
Retatrutide
1.2 / 5 mg · Vial
~6 days left · refill soon
Medication Levels
7 Days2 Weeks1 Month90 Days
CURRENT LEVEL
5.42mg
Mar 6
Today
ACTIVE MEDICATIONS
Foxo4 DriRetatrutide
0mg2.7mg5.4mg
18
Total Injections
💉 All time
122/78
Average BP
🩺 mmHg
8.4
Avg Mood
😊 /10
Health Chart
1mAll
218.6lb
↓ 8.4 lb · 3.7%
WeightInjectionsBPMood
2282222162102277.5mg7.5mg4mg10mg218
Feb 6Feb 14Feb 22Mar 2Today
Photos
12 photos · 2w streak
Week 1
Week 7
Today
Scheduled Reminders
Weight
Due today
Mood
Done
Blood Pressure
Tomorrow
Body Measurements
In 3 days
01WHAT TO TRACK

Senolytic Mechanism: Clearing Zombie Cells

01
🔬
Senescent Cell Problem
Aging cells that stop dividing but refuse to die. Secrete pro-inflammatory SASP cytokines. Accumulate with age, causing tissue dysfunction
02
🔬
FOXO4-p53 Disruption
FOXO4 protein keeps senescent cells alive. FOXO4-DRI peptide blocks FOXO4-p53 interaction. p53 is freed to trigger apoptosis in senescent cells
03
🔬
Selective Clearance
Healthy cells have MDM2-regulated p53 (protected). Senescent cells lack MDM2 suppression. Specificity for senescent cell apoptosis
04
🔬
Why Senescent Cell Clearance Matters
Senescent cells increase dramatically from age 40 onward and can represent 15–20% of total cells in some aging tissues. Their SASP secretions drive chronic inflammation, impair stem cell niches, and a
02BACKGROUND

Original Research Results

Naturally aged mice showed restored fitness, fur coat, and grip strength after FOXO4-DRI treatment.

IP injection dose used in the original 2017 Nature Medicine study in mice.

Dosing frequency used in the original mouse protocol and adapted for biohacking.

03DEEP DIVE

FOXO4-DRI Protocol Approaches

Critical note: No human clinical trials exist. FOXO4-DRI is purely investigational. The theoretical risk of off-target apoptosis in healthy cells makes physician oversight and careful monitoring essential. Track all biomarkers and subjective changes in the Shotlee app.

04DEEP DIVE

Senolytic Research Timeline

First demonstration that clearing senescent cells in mice prevents age-related tissue pathologies (Baker et al., Nature).

de Keizer/Hoeijmakers publish FOXO4-DRI in Nature Medicine — dramatic aging reversal in mice.

Dasatinib + Quercetin first senolytic combination enters human trials (Mayo Clinic).

FOXO4-DRI still has no human trials. Biohacker community self-experimenting with research-grade peptide.

05WHAT TO TRACK

Vital Protocol FAQs

01
🔬
What is FOXO4-DRI peptide?
FOXO4-DRI is a modified (D-retro inverso) peptide developed by researchers Peter de Keizer and Jan Hoeijmakers. It is designed to break the FOXO4-p53 interaction that keeps senescent (zombie) cells al
02
💉
What is the FOXO4-DRI dosing protocol?
The original mouse study used 5 mg/kg by IP (intraperitoneal) injection 3 days per week for 10 days, then 3-day-per-week pulsed dosing for ongoing treatment. Human biohacking protocols typically use 1
03
📊
What were the results in the original FOXO4-DRI mouse study?
The landmark 2017 Nature Medicine paper showed that FOXO4-DRI treatment in naturally aged mice restored fitness, fur density, and kidney function. Fast-aging (XPF-ERCC1) mice showed dramatic improveme
04
🔬
Is FOXO4-DRI safe for humans?
There are no human clinical trials for FOXO4-DRI. The key theoretical safety concern is off-target apoptosis in healthy cells, though the mechanism is designed to spare normal cells with intact p53-MD
06FAQ

Guide FAQs

Senolytic peptide that selectively induces apoptosis in senescent cells by disrupting the FOXO4-p53 interaction. Anti-aging research compound.

Yes. Shotlee supports tracking Foxo4 Dri doses, side effects, and health metrics. It is free to use.

Free · Always

Track Your Foxo4 Dri Protocol in Shotlee

Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.

Download on theApp Store
Get it onGoogle Play

📚References & sources

🔗Keep exploring

All Guides
→
Trackers
→
Compare
→
Start tracking